Alligator Energy (ASX:AGE) is an Australian, ASX-listed, exploration company focused on uranium and energy related minerals, principally cobalt-nickel. Alligator’s Directors have significant experience in the exploration, development and operations of both uranium and nickel projects (both laterites and sulphides).
Copyright 2024 – Finance News Network
Source: Finance News Network
18 Jul 2023 - Dr Shane Oliver, Chief Economist at AMP, discusses the impact of interest rates and alternatives for fighting inflation.
Read More01 Jul 2022 - Shaw and Partners Chief Investment Officer Martin Crabb discusses market outlook and which sectors and stocks do well in a downturn.
Read More20 Dec 2023 - Explore the latest developments with BluGlass CEO Jim Haden as he delves into the company's significant defense contract win and the strategic acquisition of GaNWorks. Discover how these milestones drive BluGlass' position at the forefront of quantum laser innovation in 2024, unlocking new potentials in defense, quantum computing, and beyond.
Read More13 May 2025 - Mission-critical communications with global expansion potential.
Read More08 Sep 2021 - Knosys Limited (ASX:KNO) Managing Director John Thompson discusses FY21 results and the outlook for FY22.
Read More07 Dec 2020 - ResApp Health Limited (ASX:RAP) CEO and Managing Director Dr Tony Keating provides an update on the company's growing suite of apps for the diagnosis and management of respiratory conditions and sleep apnoea, discussing its launch of the ResAppDx smartphone-based acute respiratory diagnostic test.
Read More04 Sep 2023 - Scott Duncombe, Exploration Manager of North Stawell Minerals (ASX:NSM), provides an update on the company's gold exploration.
Read More22 Nov 2023 - Jonathan Fisher serves as the CEO of Cauldron Energy (ASX:CXU). Cauldron Energy is primarily engaged in exploration activities, with a specific focus on uranium and critical minerals in the Western Australia region.
Read More23 Mar 2022 - James Power, the General Manager - Investor Relations and Marketing of the Rural Funds Group (ASX:RFF), presents on the company's HY22 results.
Read More26 May 2025 - Strong results in soft tissue sarcoma have capped off a busy quarter of immunotherapy progress
Read More
